Literature DB >> 8148216

Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine- and bradykinin-induced changes in nasal airway patency.

C E Austin1, J C Foreman.   

Abstract

1. Acoustic rhinometry is a relatively new method for objectively assessing nasal airway patency. In this paper we compare acoustic rhinometry with active posterior rhinomanometry. 2. Twenty normal healthy volunteers underwent nasal challenge with either histamine or bradykinin, 100 micrograms to 1000 micrograms, and responses were assessed by acoustic rhinometry. A further 20 subjects received identical nasal challenges and responses were assessed by active posterior rhinomanometry. 3. On a subsequent occasion, the subjects challenged previously with histamine, were given the selective H1-receptor antagonist, cetirizine, 10 mg orally, 3 h before repeat nasal challenge with histamine, 100-1000 micrograms. Again, responses were assessed by active posterior rhinomanometry and acoustic rhinometry. 4. The acoustic reflection measurements and the nasal airway resistance measurements showed comparable, significant dose-related changes in nasal patency to both histamine and bradykinin. Pretreatment with cetirizine blocked the histamine-induced change in nasal patency as measured by both methods. 5. We conclude that acoustic rhinometry has a number of advantages over posterior rhinomanometry. It is quick to perform, requires minimal subject co-operation and gives a reliable objective, measurement of dose-related changes in nasal airway patency before and after pharmacological treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148216      PMCID: PMC1364706          DOI: 10.1111/j.1365-2125.1994.tb04235.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat.

Authors:  D Proud; C J Reynolds; S Lacapra; A Kagey-Sobotka; L M Lichtenstein; R M Naclerio
Journal:  Am Rev Respir Dis       Date:  1988-03

2.  Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.

Authors:  J Bousquet; B Lebel; I Chanal; A Morel; F B Michel
Journal:  J Allergy Clin Immunol       Date:  1988-11       Impact factor: 10.793

3.  Assessment of nasal airway patency: a comparison of four methods.

Authors:  M J Gleeson; L J Youlten; D M Shelton; M Z Siodlak; N M Eiser; C L Wengraf
Journal:  Clin Otolaryngol Allied Sci       Date:  1986-04

4.  Comparing measurements of nasal resistance by body plethysmography and by rhinomanometry.

Authors:  D Nolte; I Lüder-Lühr
Journal:  Respiration       Date:  1973       Impact factor: 3.580

5.  Significance of anterior and posterior technique in rhinomanometry.

Authors:  A E Kortekangas
Journal:  Acta Otolaryngol       Date:  1972 Feb-Mar       Impact factor: 1.494

6.  Histamine and allergen induced changes in nasal airways resistance measured by anterior rhinomanometry: reproducibility of the technique and the effect of topically administered antihistaminic and anti-allergic drugs.

Authors:  O J Corrado; S Ollier; M J Phillips; J M Thomas; R J Davies
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

7.  Tracheal cross-sectional areas from acoustic reflections in dogs.

Authors:  A C Jackson; J R Krevans
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-08

8.  Airway area by acoustic response measurements and computerized tomography.

Authors:  A D D'Urzo; V G Lawson; K P Vassal; A S Rebuck; A S Slutsky; V Hoffstein
Journal:  Am Rev Respir Dis       Date:  1987-02

9.  Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever.

Authors:  M G Britton; D W Empey; G C John; K A McDonnell; D T Hughes
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

10.  Pharyngeal cross-sectional area in normal men and women.

Authors:  I G Brown; N Zamel; V Hoffstein
Journal:  J Appl Physiol (1985)       Date:  1986-09
View more
  13 in total

1.  Bradykinin in health and disease: proceedings of the Bradykinin Symposium 2012, Berlin 23-24 August 2012.

Authors:  Markus Magerl; Michael Bader; Anne Gompel; Kusumam Joseph; Allen P Kaplan; Georg Kojda; Thomas Renné; Markus Wirth; Marcus Maurer; Martin K Church
Journal:  Inflamm Res       Date:  2013-12-08       Impact factor: 4.575

2.  Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.

Authors:  P J Turner; J R Maggs; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Acoustic evaluation of the efficacy of medical therapy for allergic nasal obstruction.

Authors:  M Yamagiwa
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.

Authors:  J W Dear; K Wirth; G K Scadding; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage.

Authors:  C E Austin; J C Foreman; G K Scadding
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

6.  Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.

Authors:  P J Turner; J W Dear; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

7.  Histamine receptors that influence blockage of the normal human nasal airway.

Authors:  Thomas Taylor-Clark; Reena Sodha; Ben Warner; John Foreman
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

8.  Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.

Authors:  J W Dear; S Ghali; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Reduction by NG-nitro-L-arginine methyl ester (L-NAME) of antigen-induced nasal airway plasma extravasation in human subjects in vivo.

Authors:  J W Dear; G K Scadding; J C Foreman
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Continuous nasal positive airway pressure with a mouth leak: effect on nasal mucosal blood flux and nasal geometry.

Authors:  M J Hayes; F B McGregor; D N Roberts; R C Schroter; N B Pride
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.